Posted by: bocxman In reply to: JAZZ ONE who wrote msg# 691 Date:7/18/2005 11:37:31 PM Post #of 3031
Jazz One your analysis is much appreciated as I have been unable to listen to the webcast. It simply doesn't work on my computer for some reason.
Regarding the comment "we expect revenues in the first couple of years to be in the 10's of millions with no further expense on our part"
-- Quick and dirty analysis on the good dr.'s projection...Expenses are currently around $1 mil. Let's take $20 mil in revs, and 50 mil shares outstanding, and a biotech industry standard p/e of 30. That's .38 EPS, or $11.40/share!! Now let's discount back 20% for time/risk and we get $9.12/share.
So think of it this way...every $20 mil in licensee revenue is worth around $9/share to BOCX.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.